Differential expression of multiple transglutaminases in human brain - Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease

被引:197
作者
Kim, SY
Grant, P
Lee, JH
Pant, HC
Steinert, PM
机构
[1] NIAMS, Skin Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA
[3] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea
关键词
D O I
10.1074/jbc.274.43.30715
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transglutaminase (TGase) family of enzymes, of which seven different members are known in the human genome, participate in many biological processes involving cross-linking proteins into large macromolecular assemblies. The TGase 2 enzyme is known to be present in neuronal tissues and may play a role in neuronal degenerative diseases such as Alzheimer's disease (AD) by aberrantly cross-linking proteins. In this paper, we demonstrate by reverse transcriptase-polymase chain reaction and immunological methods with specific antibodies that in fact three members, the TGase 1, TGase 2, and TGase 3 enzymes, and are differentially expressed in various regions of normal human brain tissues. Interestingly, the TGase 1 and 3 enzymes and their proteolytically processed forms are involved in terminal differentiation programs of epithelial cell development and barrier function. In addition, we found that the levels of expression and activity of the TGase 1 and 2 enzymes were both increased in the cortex and cerebellum of AD patients. Furthermore, whereas normal brain tissues contain approximate to 1 residue of cross-link/10,000 residues, AD patient cortex and cerebellum tissues contain 30-50 residues of cross-link/10,000 residues. Together, these findings suggest that multiple TGase enzymes are involved in normal neuronal structure and function, but their elevated expression and cross-linking activity may also contribute to neuronal degenerative disease.
引用
收藏
页码:30715 / 30721
页数:7
相关论文
共 52 条
[1]  
Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437
[2]   EFFECTS OF DEPOLARIZING AGENTS ON TRANSGLUTAMINASE ACTIVITY, CA2+ INFLUX, AND PROTEIN-SYNTHESIS IN SUPERIOR CERVICAL AND NODOSE GANGLIA EXCISED FROM RATS [J].
ANDO, M ;
NAGATA, Y .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1993, 19 (1-2) :121-135
[3]   STIMULATION BY ACETYLCHOLINE AND INHIBITION BY NOREPINEPHRINE OF TRANSGLUTAMINASE ACTIVITY IN SUPERIOR CERVICAL-GANGLIA EXCISED FROM ADULT-RATS [J].
ANDO, M ;
NAKASHIMA, Y ;
NAGATA, Y .
NEUROSCIENCE RESEARCH, 1991, 12 (02) :356-365
[4]   CALPAIN ACTIVATES 2 TRANSGLUTAMINASES FROM PORCINE SKIN [J].
ANDO, Y ;
IMAMURA, S ;
MURACHI, T ;
KANNAGI, R .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1988, 280 (06) :380-384
[5]   Localization of transglutaminase in hippocampal neurons: Implications for Alzheimer's disease [J].
Appelt, DM ;
Kopen, GC ;
Boyne, LJ ;
Balin, BJ .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (12) :1421-1427
[6]  
Bae CD, 1995, KOREAN J BIOCHEM, V27, P239
[7]   TRANSGLUTAMINASE CATALYZES THE FORMATION OF SODIUM DODECYL SULFATE-INSOLUBLE, ALZ-50-REACTIVE POLYMERS OF TAU [J].
DUDEK, SM ;
JOHNSON, GVW .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :1159-1162
[8]  
FACCHIANO F, 1993, J BIOL CHEM, V268, P4588
[9]   INDUCTION AND ACTIVATION OF TISSUE TRANSGLUTAMINASE DURING PROGRAMMED CELL-DEATH [J].
FESUS, L ;
THOMAZY, V ;
FALUS, A .
FEBS LETTERS, 1987, 224 (01) :104-108
[10]  
FOLK JE, 1985, METHOD ENZYMOL, V113, P358